Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
2C-T is not habit-forming and the desire to use it can actually decrease with use. It is most often self-regulating.
The exact toxic dosage is unknown. The toxicity and long-term health effects of recreational 2C-T use do not seem to have been studied in any scientific context.
2C-T emerged from collaborative research between pharmacologist David E. Nichols and chemist Alexander Shulgin, with the compound first appearing in scientific literature in 1976. The substance was subsequently documented in greater detail in Shulgin's 1991 book PiHKAL (Phenethylamines I Have Known…
Classified as a controlled substance under Schedule III of the Controlled Drugs and Substances Act as of October 31, 2016. Listed as a derivative of 2,5-dimethoxyphenethylamine.
Not explicitly scheduled under federal law; however, its structural and pharmacological similarity to scheduled compounds such as 2C-T-7 may subject possession and sale to prosecution under the Federal Analog Act when intended for human consumption. Operation Web Tryp, commenced in 2004, resulted in prosecutions and convictions of online vendors selling similar phenethylamine compounds.
Controlled under the Misuse of Drugs Act 1971. Designated as Class A due to the phenethylamine catch-all clause, which captures structurally related phenethylamine compounds regardless of explicit scheduling.
7 sources cited